ReMuS in America - poster at the prestigious American Academy of Neurology Congress
The results of Dr. Dominika Št'astná's analysis are currently being presented at the ongoing AAN Congress.
Multiple sclerosis is a serious neurological disease that affects more than 700 people, mostly young people, in the Czech Republic every year. Although the disease is treatable with various drugs, it is not yet possible to cure the patient completely. In order to improve the treatment approach in the long term, it is essential to have a large amount of knowledge and reliable data. That is why the ReMuS registry was founded in 2013 to collect this data on the course of the disease and its treatment and to contribute to making multiple sclerosis a curable disease one day.
The results of Dr. Dominika Št'astná's analysis are currently being presented at the ongoing AAN Congress.
For the presentation of the ReMuS registry at the International Congress on Neuroimmunological Diseases ECTRIMS, we have prepared a short presentation that will reveal what is hidden under the hood of this registry. Download the PDF to find out more...
A new study published in the Journal of Central Nervous System Disease provides insights into the efficacy of cladribine in the treatment of multiple sclerosis in real-world clinical practice. This paper uses data from the Czech nationwide ReMuS registry and...
Thank you for joining us in celebrating a decade of the registry with a benefit concert performed by Kateřina Marie Tichá & Bandjeez and guests in the beautiful refectory of Emmaus Abbey.
02/
11/
2023
The traditional meeting place for expert neurologists is named after Prof. Pavel Jedlicka, a pioneer in the field of treatment of demyelinating diseases. The 21st Symposium will feature, besides many Czech experts, also two extraordinary foreign guests - prof. Roland Martin from Switzerland and Dr. Eva Strijbis from the Netherlands. You can register to participate directly here.
24-25/
5/
2024
On Friday 3 November, the 5th workshop for clinicians, nurses and registry administrators from all MS sites in the Czech Republic took place. In the Hermitage Hotel in Prague, the topics of safety monitoring using the system MedDRA, ongoing projects and activities ahead, plus new unique research opportunities were discussed.
>> more information and a photo report
03/
11/
2023